BenQ Medical Technology Corporation (TPEX:4116)

BenQ Medical Technology Income Statement

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	5,198	4,767	4,543	4,377	1,465	1,401
Revenue Growth (YoY)	11.62%	4.94%	3.80%	198.82%	4.55%	1.49%
Cost of Revenue	3,554	3,319	3,199	3,129	952.31	849.22
Gross Profit	1,644	1,448	1,344	1,247	512.28	551.63
Selling, General & Admin	1,257	1,079	947.17	855.13	423.58	409.99
Research & Development	37.22	36.39	31.96	39.58	39.65	44.3
Other Operating Expenses	-	-	-1.53	0.73	0.81	-
Operating Expenses	1,298	1,115	978.46	896.88	465.82	454.42
Operating Income	346.42	333.02	365.44	350.26	46.46	97.21
Interest Expense	-42.43	-34.22	-27.94	-17.83	-3.91	-4.02
Interest & Investment Income	12.79	11.23	10.21	5.24	0.69	0.8
Earnings From Equity Investments	-	-	-57.38	-125.05	1.79	4.15
Currency Exchange Gain (Loss)	-16.57	8.98	-2.5	3.44	-0.53	-3.52
Other Non Operating Income (Expenses)	15.82	10.91	17.15	14.28	16.56	10.4
EBT Excluding Unusual Items	316.04	329.91	304.98	230.33	61.06	105.03
Gain (Loss) on Sale of Investments	4.45	-	5.13	-	-	-
Gain (Loss) on Sale of Assets	15.5	-0.9	-0.03	3.85	0.06	0.07
Other Unusual Items	0.06	0.37	0.09	81.57	0.66	0.57
Pretax Income	336.04	329.38	310.17	315.74	61.78	105.67
Income Tax Expense	105.09	92.13	109.91	79.15	12.75	21.55
Earnings From Continuing Operations	230.95	237.25	200.26	236.6	49.04	84.12
Minority Interest in Earnings	-145.16	-132.42	-85.68	-56.35	-20.2	-22.07
Net Income	85.79	104.83	114.58	180.24	28.84	62.05
Net Income to Common	85.79	104.83	114.58	180.24	28.84	62.05
Net Income Growth	-25.72%	-8.51%	-36.43%	524.98%	-53.52%	-17.71%
Shares Outstanding (Basic)	45	45	45	45	45	45
Shares Outstanding (Diluted)	45	45	45	45	45	45
Shares Change (YoY)	0.00%	0.02%	-0.07%	0.42%	-0.30%	-0.09%
EPS (Basic)	1.93	2.35	2.57	4.04	0.65	1.39
EPS (Diluted)	1.92	2.34	2.56	4.02	0.65	1.39
EPS Growth	-25.56%	-8.59%	-36.32%	521.20%	-53.44%	-17.26%
Free Cash Flow	230.82	52.14	308.88	405.95	91.09	115.07
Free Cash Flow Per Share	5.15	1.16	6.89	9.05	2.04	2.57
Dividend Per Share	1.650	1.650	2.000	2.100	0.500	1.000
Dividend Growth	-17.50%	-17.50%	-4.76%	320.00%	-50.00%	-25.93%
Gross Margin	31.63%	30.38%	29.58%	28.50%	34.98%	39.38%
Operating Margin	6.66%	6.98%	8.04%	8.00%	3.17%	6.94%
Profit Margin	1.65%	2.20%	2.52%	4.12%	1.97%	4.43%
Free Cash Flow Margin	4.44%	1.09%	6.80%	9.28%	6.22%	8.21%
EBITDA	527.53	509.07	532.15	520.51	107.71	146.02
EBITDA Margin	10.15%	10.68%	11.71%	11.89%	7.36%	10.42%
D&A For EBITDA	181.11	176.05	166.72	170.24	61.25	48.81
EBIT	346.42	333.02	365.44	350.26	46.46	97.21
EBIT Margin	6.66%	6.98%	8.04%	8.00%	3.17%	6.94%
Effective Tax Rate	31.27%	27.97%	35.43%	25.07%	20.63%	20.39%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.